We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
(Approval lapsed) HydrALAZINE Hydrochloride Tablets, USP, 25mg (hydralazine hydrochloride) tablets
Section 19A approved medicine
(Approval lapsed) HydrALAZINE Hydrochloride Tablets, USP, 25mg (hydralazine hydrochloride) tablets
Section 19A approval holder
Medsurge Healthcare Pty Ltd ABN 92 124 728 892
Phone
1300 788 261
Approved until
Status
Expired
Medicines in short supply/unavailable
ALPHAPRESS 25 hydralazine hydrochloride 25mg tablet bottle - ARTG 17575
ALPHAPRESS 50 hydralazine hydrochloride 50mg tablet bottle - ARTG 60380
ALPHAPRESS 50 hydralazine hydrochloride 50mg tablet bottle - ARTG 60380
Indication(s)
Treatment of drug resistant, moderate to severe, hypertension. This drug is not a first line antihypertensive drug and is better used in combination with other antihypertensives such as beta-blockers and diuretics.